tiprankstipranks
Trending News
More News >
Protagonist Therapeutics (PTGX)
NASDAQ:PTGX
US Market

Protagonist Therapeutics (PTGX) Technical Analysis

Compare
726 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
3Neutral
10Bearish
Technical Analysis Consensus
Buy
5Bullish
3Neutral
2Bearish
Moving Average Consensus
Sell
4Bullish
0Neutral
8Bearish
Protagonist Therapeutics’s (PTGX) Moving Averages Convergence Divergence (MACD) indicator is -1.52, suggesting Protagonist Therapeutics is a Buy.
Protagonist Therapeutics’s (PTGX) 20-Day exponential moving average is 85.02, while Protagonist Therapeutics’s (PTGX) share price is $80.25, making it a Sell.
Protagonist Therapeutics’s (PTGX) 50-Day exponential moving average is 83.49, while Protagonist Therapeutics’s (PTGX) share price is $80.25, making it a Sell.

Protagonist Therapeutics (PTGX) Pivot Points

Jan 14, 2026, 02:24 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
77.25
78.31
79.27
80.33
81.29
82.35
83.31
Fibonacci
78.31
79.08
79.56
80.33
81.10
81.58
82.35
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Protagonist Therapeutics (PTGX) Moving Averages

Jan 14, 2026, 02:24 PM
Period
Simple
Exponential
MA5
81.06Sell
81.39Sell
MA10
83.92Sell
83.21Sell
MA20
86.79Sell
85.02Sell
MA50
85.61Sell
83.49Sell
MA100
75.65Buy
76.91Buy
MA200
62.87Buy
65.29Buy
Protagonist Therapeutics’s (PTGX) 10-Day exponential moving average is 83.21, while Protagonist Therapeutics’s (PTGX) share price is $80.25, making it a Sell.
Protagonist Therapeutics’s (PTGX) 100-Day exponential moving average is 76.91, while Protagonist Therapeutics’s (PTGX) share price is $80.25, making it a Buy.
Protagonist Therapeutics’s (PTGX) stock price is $80.25 and Protagonist Therapeutics’s (PTGX) 50-day simple moving average is 85.61, creating a Sell signal.
Protagonist Therapeutics’s (PTGX) stock price is $80.25 and Protagonist Therapeutics’s (PTGX) 100-day simple moving average is 75.65, creating a Buy signal.
Protagonist Therapeutics’s (PTGX) stock price is $80.25 and Protagonist Therapeutics’s (PTGX) 200-day simple moving average is 62.87, creating a Buy signal.

Protagonist Therapeutics (PTGX) Technical Indicators

Jan 14, 2026, 02:24 PM
Name
Value
Implied Action
RSI (14)
33.34
Neutral
STOCH (9,6)
11.98
Buy
STOCHRSI (14)
10.79
Buy
MACD (12,26)
-1.52
Buy
ADX (14)
27.54
Neutral
Williams %R
-86.67
Buy
CCI (14)
-143.16
Buy
ATR (14)
2.97
-
Ultimate Oscillator
48.99
Neutral
ROC
-6.74
Sell
Protagonist Therapeutics’s (PTGX) Relative Strength Index (RSI) is 33.34, creating a Neutral signal.
Protagonist Therapeutics’s (PTGX) Trend Strength Indicator (ADX) is 27.54, creating a Neutral signal.
Protagonist Therapeutics’s (PTGX) Commodity Channel Index (CCI) is -143.16, creating a Buy signal.
Protagonist Therapeutics’s (PTGX) Price Rate of Change (ROC) is -6.74, creating a Sell signal.

FAQ

Is PTGX a Buy, Hold, or Sell?
Based on PTGX’s technical indicators, PTGX is a Hold.
    What is PTGX’s RSI (14)?
    PTGX’s RSI (14) is 33.34, which suggests PTGX is a Neutral.
      What is PTGX’s MACD?
      PTGX’s MACD is -1.52, which suggests PTGX is a Buy.
        What is PTGX’s 5-day moving average?
        PTGX’s 5-day moving average is 81.06, which suggests PTGX is a Sell.
          What is PTGX’s 20-day moving average?
          PTGX 20-day moving average is 86.79, which suggests PTGX is a Sell.
            What is PTGX’s 50-day moving average?
            PTGX’s 50-day moving average is 85.61, which suggests PTGX is a Sell.
              What is PTGX’s 200-day moving average?
              PTGX’s 200-day moving average is 62.87, which suggests PTGX is a Buy.
                What is PTGX’s Williams % R (14)?
                PTGX’s Williams % R (14) is -86.67, which suggests PTGX is a Buy.
                  What is PTGX’s CCI (14)?
                  PTGX’s CCI (14) is -143.16, which suggests PTGX is a Buy.